US court tests the breadth of patent protection on proteins

Article Abstract:

Biotechnology firm Amgen is suing Transkaryotic Therapies (TKT), claiming infringement of a number of patents on its anti-anaemia drug Epogen. TKT researchers have identified an alternative way to produce erythropoietin, the hormone which encourages the production of red blood cells.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Spitzer sues drug giant for deceiving doctors

Article Abstract:

Eliot Spitzer, the politically ambitious attorney general of New York State, sued Glaxo-Smithkline (GSK) for allegedly suppressing negative results of trials on 2 June 2004. The GSK lawsuit opens a new front in a wider war that Spitzer has declared against corporate targets.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Merck settles Vioxx lawsuits for $4.85 billion

Article Abstract:

The article gives a brief account of pharmaceutical company Merck's decision of paying $4.85 billion to settle down various lawsuits that blame the painkiller Vioxx of causing heart attacks and strokes to its patients.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: